Man Group plc - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Man Group plc ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$52,638
-62.9%
35,092
-46.5%
0.00%
Q3 2021$142,000
-68.5%
65,591
-49.2%
0.00%
-100.0%
Q2 2021$451,000
-7.2%
128,991
+161.7%
0.00%0.0%
Q1 2021$486,000
-67.1%
49,297
-63.9%
0.00%
-66.7%
Q4 2020$1,479,000
+0.3%
136,423
-4.7%
0.01%0.0%
Q3 2020$1,474,000
+629.7%
143,123
+271.7%
0.01%
+500.0%
Q1 2019$202,000
-88.2%
38,506
-92.9%
0.00%
-87.5%
Q4 2018$1,710,000
-49.8%
542,893
-3.6%
0.01%
-33.3%
Q3 2018$3,406,000
-28.2%
562,893
-37.1%
0.01%
-40.0%
Q2 2018$4,745,000
-37.4%
895,249
-31.5%
0.02%
-42.9%
Q1 2018$7,575,0001,306,0480.04%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders